An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas

An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas

Background. We performed a retrospective study to assess whether the initial molecular characteristics of glioblastomas (GBMs) were associated with the response to the bevacizumab/irinotecan chemotherapy regimen given at recurrence. Results. Comparison of the genomic and gene expression profiles o...

Full description

Bibliographic Details
Main Authors: Laffaire, Julien, Stefano, Anna Luisa Di, Chinot, Olivier, Idbaih, Ahmed, Gallego Perez-Larraya, Jaime, Marie, Yannick, Vintonenko, Nadia, Boisselier, Blandine, Farina, Patrizia, Delattre, Jean-Yves, Figarella-Branger, Dominique, Honnorat, Jérôme, Sanson, Marc, Ducray, François
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996912/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996912/

Similar Items